Heather C. Getz - 03 Aug 2026 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Aug 2026, 16:09:42 UTC
Prior SEC filing
26 Jun 2026
Next SEC filing
17 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Megan Smeykal, Attorney-in-Fact

Key filing fact

Heather C. Getz filed Form 4 for TELA Bio, Inc. (TELA) on 05 Aug 2026.

Key facts

  • This page summarizes Heather C. Getz's Form 4 filing for TELA Bio, Inc. (TELA).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Aug 2026, 16:09.

Change

  • Previous filing in this sequence was filed on 26 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001481485 Primary reporting owner

Getz Heather C

Relationship
Chief Executive Officer, Director
Address
C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN
Signature
/s/ Megan Smeykal, Attorney-in-Fact
Signature date
05 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TELA transaction

Common Stock

Award

Transaction value
Shares
+500,000
Change %
+10000%
Price
$0.000000*
Shares after
505,000
Date
03 Aug 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TELA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+1,365,000
Change %
Price
$0.000000*
Shares after
1,365,000
Date
03 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,365,000
Exercise price
$0.7400
Footnotes
F2
TELA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+1,005,000
Change %
Price
$0.000000*
Shares after
1,005,000
Date
03 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,005,000
Exercise price
$0.9000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These restricted stock units will vest in four equal annual installments beginning on August 3, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Footnote F2

The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .